Groundbreaking Medication Soon Available for Australians With Specific Type Of MND | 10 News

By 10 News

Community Score: 50% | 118 views | 1mo

0 community ratings: null thumbs up, null thumbs down

Australians with a specific type of motor neurone disease will soon have access to a groundbreaking drug that helps slow its progression. From October, Qalsody will be listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of patients with a form of amyotrophic lateral sclerosis (ALS). The cost will drop from up to $28,600 per script to a maximum of $25. Join the conversation and follow us on: X: https://x.com/10NewsAU Facebook: http://www.facebook.com/10NewsAU/ Instagram: http://www.instagram.com/10NewsAU/ TikTok: https://www.tiktok.com/@10NewsAU LinkedIn: https://www.linkedin.com/company/10newsau 10 News airs at 5pm, seven nights a week in your local market on Network 10. Missed the bulletin? Catch up at https://10.com.au/news 10 News is based in Australia and is a division of Paramount.

Tags: disease, health news, jai arrow, jai arrow mnd, medical condition, mnd, mnd research, news, top news stories